BioProtect Secures $28M to Commercialize its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy
TZUR IGAL, Israel – BioProtect Ltd, a private Med Tech company focused on providing innovative, biodegradable spacing solutions, announced today the successful close of a $28 million funding. The round was …
BioProtect LTD announces new GM and Chief Commercial Officer in the US
TZUR IGAL, Israel, August 28, 2023 – Israeli medical devices manufacturer BioProtect Ltd. announced that it has nominated Ken Knudson as General Manager and Chief Commercial Officer effective August 1, 2023. …
BioProtect receives FDA’s clearance for its biodegradable balloon for rectal protection during prostate cancer radiation therapy
TZUR IGAL, Israel, August 28, 2023 – Israeli medical devices manufacturer BioProtect Ltd. announced today that their BioProtect Balloon ImplantTM System has been cleared by the FDA. The biodegradable balloon is a …